U.S.: FTC, animal health co reach agreement on distribution exclusivity deals
IDEXX Laboratories Inc has signed a Consent Agreement with the Federal Trade Commission to settle an investigation into whether the diagnostics and information technology solutions company had hampered competition. The company specializes in animal health as well as water and milk supply quality. Under terms of the agreement, IDEXX can no longer have exclusive distribution contracts with three veterinary companies at once. The three companies named are MWI Veterinary Supply, Inc., Butler Schein Animal Health and Webster Veterinary. The agreement says that IDEXX can maintain those exclusivity agreements with two at once, however. IDEXX has not admitted to any legal misdoings, and its CEO and chairman Jonathan Ayers said in a statement that the agreement is a “milestone” in resolving the investigation.
Featured News
Canada Intensifies Scrutiny of AI Risks in Banking Sector
Jul 13, 2026 by
CPI
Second Circuit Upholds Injunction Against Nielsen in Radio Ratings Antitrust Fight
Jul 13, 2026 by
CPI
TransDigm Abandons $960M Stellant Systems Acquisition After US Antitrust Pushback
Jul 13, 2026 by
CPI
Administration Expands Effort to Keep AI-Driven Electricity Costs Off Consumer Bills
Jul 13, 2026 by
CPI
Mexican Lawmakers Move to Challenge Sony Over Potential PlayStation Store Monopoly
Jul 13, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Due Process
Jul 7, 2026 by
CPI
The Hart‑Scott‑Rodino Act at Fifty: Procedure, Thresholds, Serial Acquisitions, and Industry Dynamics
Jul 7, 2026 by
Ginger Zhe Jin, Mario Leccese, Daniel Sokol, Liad Wagman & Mengyi Zhong
Due Process In Competition Cases: Reflections As Of 2026
Jul 7, 2026 by
Ian Forrester & Pablo Trevisan
When Referees Become Reformers: Due Process and Constitutional Considerations in Competition Market Investigations
Jul 7, 2026 by
John Taladay & Christine Ryu-Naya
Procedural Fairness in Antitrust Enforcement: A Comparative Analysis
Jul 7, 2026 by
J. Mark Gidley & Daniel Sokol